Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study
- PMID: 27027368
- PMCID: PMC4811280
- DOI: 10.5935/abc.20160033
Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
References
-
- Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–2397. - PubMed
-
- Kastelein JJP, Akdim F, Stroes ESG, Zwinderman AH, Bots ML, Stalenhoef AFH, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14):1431–1443. - PubMed
-
- Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. Use of ezetimibe in the united states and canada. N Engl J Med. 2008;358(17):1819–1828. - PubMed
-
- Yusuf S, Zhac F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation. N Engl J Med. 2001;345(7):494–502. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical